Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

34
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
34
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

107
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
107
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

69
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
69
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

1.9K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.9K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

2.0K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.0K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

4.9K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surveillance for Candida auris - United States, 2022-2024.

Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002)·2026
Same author

Disaggregation of between- and within-subject effects of internalizing symptoms on P300 amplitude during adolescence.

Development and psychopathology·2026
Same author

Genetically Similar High-Risk Strains of Carbapenemase-Producing Enterobacterales in Humans and Companion Animals, United States.

Emerging infectious diseases·2026
Same author

New Delhi metallo-β-lactamase-producing Acinetobacter baumannii in the USA from October, 2013, to March, 2022: a retrospective molecular epidemiological analysis.

The Lancet. Microbe·2026
Same author

Projected impact of a pathogen reduction intervention on carbapenem-resistant Enterobacterales bloodstream infections and deaths in the United States.

Infection control and hospital epidemiology·2026
Same author

Evidence for Reduced Monitoring of Children's Laboratory Task Performance by Punitive Parents: An ERP Study.

Research on child and adolescent psychopathology·2026

Related Experiment Video

Updated: Apr 3, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

25.3K

Vancomycin-Resistant Staphylococcus aureus - Delaware, 2015.

Maroya Spalding Walters, Paula Eggers, Valerie Albrecht

    MMWR. Morbidity and Mortality Weekly Report
    |September 25, 2015
    PubMed
    Summary

    Vancomycin-resistant Staphylococcus aureus (VRSA) is a rare, multidrug-resistant bacterium. VRSA emerges when resistance genes transfer from vancomycin-resistant enterococci (VRE) to methicillin-resistant Staphylococcus aureus (MRSA).

    More Related Videos

    Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
    12:18

    Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

    Published on: February 9, 2011

    23.8K
    Multiplex PCR Assay for Typing of Staphylococcal Cassette Chromosome Mec Types I to V in Methicillin-resistant Staphylococcus aureus
    09:03

    Multiplex PCR Assay for Typing of Staphylococcal Cassette Chromosome Mec Types I to V in Methicillin-resistant Staphylococcus aureus

    Published on: September 5, 2013

    12.4K

    Related Experiment Videos

    Last Updated: Apr 3, 2026

    Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
    14:04

    Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

    Published on: May 8, 2013

    25.3K
    Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
    12:18

    Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

    Published on: February 9, 2011

    23.8K
    Multiplex PCR Assay for Typing of Staphylococcal Cassette Chromosome Mec Types I to V in Methicillin-resistant Staphylococcus aureus
    09:03

    Multiplex PCR Assay for Typing of Staphylococcal Cassette Chromosome Mec Types I to V in Methicillin-resistant Staphylococcus aureus

    Published on: September 5, 2013

    12.4K

    Area of Science:

    • Microbiology
    • Infectious Diseases
    • Antimicrobial Resistance

    Background:

    • Vancomycin-resistant Staphylococcus aureus (VRSA) is a rare but significant public health threat.
    • VRSA strains are multidrug-resistant and have emerged globally.
    • All identified VRSA strains originated from methicillin-resistant Staphylococcus aureus (MRSA).

    Purpose of the Study:

    • To document the emergence and characteristics of VRSA in the United States.
    • To highlight the genetic mechanisms of vancomycin resistance transfer.
    • To emphasize the public health implications of VRSA.

    Main Methods:

    • Surveillance of VRSA isolates reported to the Centers for Disease Control and Prevention (CDC).
    • Molecular characterization of vancomycin resistance genes, including the vanA operon.
    • Tracking the origins of VRSA from MRSA strains.

    Main Results:

    • The fourteenth VRSA isolate in the United States was identified in February 2015.
    • VRSA arises from the transfer of vancomycin resistance genes (e.g., vanA) from vancomycin-resistant enterococci (VRE).
    • The vanA operon facilitates resistance by modifying or eliminating the vancomycin binding site.

    Conclusions:

    • VRSA represents a critical challenge in managing Staphylococcus aureus infections.
    • Understanding the transfer of resistance genes is crucial for preventing VRSA spread.
    • Continued surveillance and research are necessary to combat the threat of multidrug-resistant bacteria.